OSE Immunotherapeutics Employee Directory

Biotechnology ResearchPAYS DE LA LOIRE, France51-200 Employees

OSE Immunotherapeutics, société intégrée de biotech qui développe des produits first-in-class dans le cancer et les maladies inflammatoires.
Portefeuille clinique first-in-class 
•	Tedopi® (immunothérapie spécifique à base de cellules T): résultats positifs de Ph 3 dans le CPNPC en résistance secondaire après échec d’un inhibiteur de point de contrôle. Autres essais promus par des groupes cliniques en onco en combo en cours dans des tumeurs solides
•	OSE-279 (anti-PD1) au stade préclinique avancé
•	OSE-127 (mAb humanisé antagoniste d’IL-7R):  Ph 2 en cours dans la rectocolite hémorragique; travaux de recherche préclinique en cours dans les leucémies 
•	VEL-101/FR104 (mAb anti-CD28) : partenariat avec Veloxis dans la transplantation; Ph 1/2 en cours dans la transplantation rénale (promotion CHU Nantes) ; Ph 1 en cours aux US (promoteur Veloxis)
•	BI 765063 (mAb anti-SIRPα sur l’axe SIRPα/CD-47): partenariat avec Boehringer Ingelheim dans les tumeurs solides avancées; résultats positifs de la Ph 1 d’escalade de dose en mono et en combo, en particulier avec l’anticorps anti-PD1 ezabenlimab; Ph 1b promue par BI en cours en combo avec ezabenlimab seul ou avec d’autres médicaments dans le cancer de la tête et du cou en rechute/métastatique et dans CHC 
OSE Immunotherapeutics développe deux plateformes de recherche brevetées dont l’objectif est de délivrer des traitements d’immunothérapie first-in-class:  
•	Plateforme BiCKI® ciblée sur l’immuno-oncologie (IO), protéines de fusion bispécifiques construite autour d’une ossature centrale anti-PD-1 fusionnée à de nouvelles cibles d’immunothérapies pour augmenter l’efficacité antitumorale. Le candidat le plus avancé, BiCKI®-IL-7 cible anti-PD1xIL-7 
•	Plateforme Myéloïdes vise à optimiser le potentiel thérapeutique des cellules myéloïdes en IO et immuno-inflammation (I&I). OSE-230 (anticorps agoniste de ChemR23), candidat le plus avancé de cette plateforme; il a le potentiel de résoudre l’inflammation chron

Find OSE Immunotherapeutics employees' phone numbers or email addresses

OSE Immunotherapeutics Global Highlights

Europe
99

France
96
United Kingdom Of Great Britain And Northern Ireland
1
Switzerland
1
Belgium
1

North America
3

United States Of America
2
Canada
1

Asia
2

India
1
Philippines
1

South America
1

Uruguay
1

OSE Immunotherapeutics's Leadership

N. P.
Chief Executive Officer
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. A. P. M.
Chief Business Officer
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
B. V.
Chief Medical Officer Immuno Oncology
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
F. C.
Chief Medical Officer Immunology
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
L. C.
Chief Of Translational Research And Alliances
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. C.
Head Of Clinical Development And Regulatory Affairs
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. M.
Head Of Research, Director Of R&d Program
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. C.
Chairwoman And Chief Of Strategy And Developement At Ose Immunotherapeutics
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

OSE Immunotherapeutics Employee Metrics

100%

50%

0%

2024

2023

Program & Project Management
Research
Engineering
Marketing
Administrative
Other

Contact profiles from OSE Immunotherapeutics

Name

Title

Contact Info

Location

Last Update

B. P.
Clinical Project Director - Early Phase Studies / Immuno-Onco
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
FranceÎle-de-France
Oct 24, 2024
C. C.
Director Clinical Operations
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
FranceÎle-de-France
Oct 24, 2024
F. D. S.
Clinical Packaging And Supply Chain Director
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
FranceÎle-de-France
Oct 24, 2024
C. A.
Director Of Therapeutic Vaccine Development (cmc) And External Drug Manufacturing
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
FranceÎle-de-France
Oct 01, 2024
E. M.
Medical Director Immuno Oncology
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
FranceÎle-de-France
Oct 17, 2024
N. M.
Director Of Cmc Biologics
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
Oct 28, 2024
V. G.
Target Discovery Director
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
Oct 11, 2024
E. S.
Director Of Strategic Partnerships
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
FranceÎle-de-France
Sep 10, 2024
F. B.
Strategic Development Director
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
FranceOccitanie
Sep 17, 2024
L. C. B.
Director Of Regulatory Affairs
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for OSE Immunotherapeutics and Millions of Other Companies
Sign up for full access to OSE Immunotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
France
Oct 21, 2024

Frequently Asked Questions

What is OSE Immunotherapeutics known for?

OSE Immunotherapeutics was founded in 2012 operates in the Biotechnology Research industry. The company's main headquarters is located in 22, avenue Bénoni Goullin NANTES, PAYS DE LA LOIRE 44200 FR. Explore OSE Immunotherapeutics's company overview page for more information.

What is OSE Immunotherapeutics's most common email format?

OSE Immunotherapeutics employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more OSE Immunotherapeutics email formats with LeadIQ.

How many employees does OSE Immunotherapeutics have currently?

OSE Immunotherapeutics has approximately 69 employees as of September 2024. These team members are located across 4 continents, including EuropeNorth AmericaAsia.

Who are OSE Immunotherapeutics's key employees and leadership?

As of September 2024, OSE Immunotherapeutics's key employees include:

Chief Executive Officer: N. P.
Chief Business Officer: J. A. P. M.
Chief Medical Officer Immuno Oncology: B. V.
Chief Medical Officer Immunology: F. C.
Chief Of Translational Research And Alliances: L. C.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking